Julio Hajdenberg MD, FACP
| Title | Associate Professor |
|---|
| Institution | UMass Chan Medical School |
|---|
| Department | Medicine at UMass Chan - Lahey |
|---|
| Address | Lahey Clinic 41 Mall Road Burlington MA 01805-0001
|
|---|
| Phone | 781-744-8400 |
|---|
| vCard | Download vCard |
|---|
|
|
|
|
| Institution | T.H. Chan School of Medicine |
|---|
| Department | Medicine at UMass Chan - Lahey |
|---|
|
|
|---|
|
Biography
| University of Buenos Aires Medical School, Buenos Aires, BA, Argentina | MD | | |
Bibliographic
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Young S, Kuzu A, Magill M, Hajdenberg J. Partial Response to Small Molecule Inhibition in a Case of Anaplastic Large Cell Lymphoma. Cureus. 2022 Mar; 14(3):e23627.
PMID: 35494913.
Citations:
-
Barish J, Hajdenberg J. Severe bleeding after haemorrhoidal banding in a haemophilia patient treated with emicizumab. Haemophilia. 2021 Jul; 27(4):e589-e590.
PMID: 34021677.
Citations:
-
Hassanein H, Hajdenberg J. High Thermal Amplitude Red Blood Cell Agglutinating Cold Type Autoantibodies in a Case of Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia and Multiorgan Failure. J Med Cases. 2021 Jan; 12(1):16-17.
PMID: 34434421.
Citations:
-
Hajdenberg J. Review: In patients with cancer, prophylactic anticoagulants reduce VTE and do not increase major bleeding. Ann Intern Med. 2019 12 17; 171(12):JC65.
PMID: 31842223.
Citations:
-
Bhatia A, Ulaner G, Rampal R, Hyman DM, Abdel-Wahab O, Durham BH, Dogan A, Ozkaya N, Lacouture ME, Hajdenberg J, Ganzel C, Diamond EL. Single-agent dabrafenib for BRAFV600E-mutated histiocytosis. Haematologica. 2018 04; 103(4):e177-e180.
PMID: 29472347.
Citations:
-
Leonard JP, Kolibaba KS, Reeves JA, Tulpule A, Flinn IW, Kolevska T, Robles R, Flowers CR, Collins R, DiBella NJ, Papish SW, Venugopal P, Horodner A, Tabatabai A, Hajdenberg J, Park J, Neuwirth R, Mulligan G, Suryanarayan K, Esseltine DL, de Vos S. Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2017 Nov 01; 35(31):3538-3546.
PMID: 28862883.
Citations:
-
Patel MD, Hajdenberg J. Successful treatment of chronic recurrent life-threatening bleeding due to an acquired factor V Inhibitor with rituximab and steroids. Haemophilia. 2016 May; 22(3):e231-2.
PMID: 27029965.
Citations:
-
Hajdenberg J. ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment. Ann Intern Med. 2016 Feb 16; 164(4):JC18.
PMID: 26882303.
Citations:
-
Faltas B, Goldenberg DM, Ocean AJ, Govindan SV, Wilhelm F, Sharkey RM, Hajdenberg J, Hodes G, Nanus DM, Tagawa ST. Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma. Clin Genitourin Cancer. 2016 Feb; 14(1):e75-9.
PMID: 26541586.
Citations:
-
John ES, Patel MD, Hajdenberg J. Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor. Case Rep Hematol. 2015; 2015:603402.
PMID: 26346326.
Citations:
-
Carilli A, Favis G, Sundharkrishnan L, Hajdenberg J. Severe dermatologic reactions with bendamustine: a case series. Case Rep Oncol. 2014 May; 7(2):465-70.
PMID: 25120473.
Citations:
-
Hajdenberg J. ACP Journal Club. Radical prostatectomy reduced long-term mortality more than watchful waiting in early prostate cancer. Ann Intern Med. 2014 Jun 17; 160(12):JC10.
PMID: 24935504.
Citations:
-
Beilan JA, Lawton A, Hajdenberg J, Rosser CJ. Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature. BMC Urol. 2013 Apr 29; 13:22.
PMID: 23627260.
Citations:
-
Beilan J, Lawton A, Hajdenberg J, Rosser CJ. Locally advanced paraganglioma of the urinary bladder: a case report. BMC Res Notes. 2013 Apr 18; 6:156.
PMID: 23594404.
Citations:
-
Feldman DR, Einhorn LH, Quinn DI, Loriot Y, Joffe JK, Vaughn DJ, Fléchon A, Hajdenberg J, Halim AB, Zahir H, Motzer RJ. A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors. Invest New Drugs. 2013 Aug; 31(4):1016-22.
PMID: 23417696.
Citations:
-
Hajdenberg J. ACP Journal Club. Review: Self-testing or self-management of oral anticoagulation reduces thromboembolic events and mortality more than usual care. Ann Intern Med. 2011 Jul 19; 155(2):JC1-6.
PMID: 21768572.
Citations:
-
Bukowski RM, Stadler WM, McDermott DF, Dutcher JP, Knox JJ, Miller WH, Hainsworth JD, Henderson CA, Hajdenberg J, Kindwall-Keller TL, Ernstoff MS, Drabkin HA, Curti BD, Chu L, Ryan CW, Hotte SJ, Xia C, Cupit L, Figlin RA. Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program. Oncology. 2010; 78(5-6):340-7.
PMID: 20733337.
Citations:
-
Stadler WM, Figlin RA, McDermott DF, Dutcher JP, Knox JJ, Miller WH, Hainsworth JD, Henderson CA, George JR, Hajdenberg J, Kindwall-Keller TL, Ernstoff MS, Drabkin HA, Curti BD, Chu L, Ryan CW, Hotte SJ, Xia C, Cupit L, Bukowski RM. Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America. Cancer. 2010 Mar 01; 116(5):1272-80.
PMID: 20082451.
Citations:
-
Hajdenberg J. ACP Journal Club. Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer. Ann Intern Med. 2009 Dec 15; 151(12):JC6-14.
PMID: 20008750.
Citations:
-
Hajdenberg J. ACP Journal Club. Adding radiotherapy to endocrine therapy improved survival in locally advanced prostate cancer. Ann Intern Med. 2009 Jun 16; 150(12):JC6-6.
PMID: 19528551.
Citations:
-
Hajdenberg J, Grote T, Yee L, Arevalo-Araujo R, Latimer LA. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting. J Support Oncol. 2006 Oct; 4(9):467-71.
PMID: 17080735.
Citations:
-
Grote T, Hajdenberg J, Cartmell A, Ferguson S, Ginkel A, Charu V. Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant. J Support Oncol. 2006 Sep; 4(8):403-8.
PMID: 17004515.
Citations:
-
Eisenberg P, Figueroa-Vadillo J, Zamora R, Charu V, Hajdenberg J, Cartmell A, Macciocchi A, Grunberg S. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer. 2003 Dec 01; 98(11):2473-82.
PMID: 14635083.
Citations:
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2003 | 1 |
| 2006 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs